Posterior cardinal vein

From WikiMD's WELLNESSPEDIA

Posterior cardinal vein is a part of the cardiovascular system that plays a crucial role in the development of the circulatory system in vertebrates. It is one of the three paired cardinal veins that are present in the early stages of embryonic development. The other two cardinal veins are the anterior cardinal vein and the common cardinal vein.

Development[edit]

The posterior cardinal vein develops from the mesoderm, one of the three primary germ layers in the early embryo. It forms on either side of the embryo and drains the blood from the posterior part of the body. As the embryo develops, the posterior cardinal vein undergoes several changes and gives rise to various parts of the adult venous system.

Function[edit]

The primary function of the posterior cardinal vein is to carry deoxygenated blood from the posterior part of the body to the heart. During the early stages of embryonic development, it serves as the main venous drainage system. However, as the embryo grows and the circulatory system develops, the role of the posterior cardinal vein diminishes and it eventually regresses.

Clinical significance[edit]

Abnormalities in the development of the posterior cardinal vein can lead to various congenital heart defects. These defects can affect the structure and function of the heart and the circulatory system, leading to a range of health problems. Some of these defects can be detected during prenatal screening and can be managed with medical or surgical interventions.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.